These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8299901)

  • 1. The role of endogenous nitric oxide and platelet-activating factor in hypoxia-induced intestinal injury in rats.
    Caplan MS; Hedlund E; Hill N; MacKendrick W
    Gastroenterology; 1994 Feb; 106(2):346-52. PubMed ID: 8299901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat.
    MacKendrick W; Caplan M; Hsueh W
    Pediatr Res; 1993 Aug; 34(2):222-8. PubMed ID: 8233729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotoxin and hypoxia-induced intestinal necrosis in rats: the role of platelet activating factor.
    Caplan MS; Kelly A; Hsueh W
    Pediatr Res; 1992 May; 31(5):428-34. PubMed ID: 1603619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation by nitric oxide of platelet-activating factor-induced albumin extravasation in the conscious rat.
    Filep JG; Földes-Filep E
    Br J Pharmacol; 1993 Dec; 110(4):1347-52. PubMed ID: 8306074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide mediates platelet activating factor-induced microvascular leakage in rat airways.
    Jeon SY; Kim EA; Ma YW; Kim JP; Jung TG; Hwang EG
    Ann Otol Rhinol Laryngol; 2001 Jan; 110(1):83-6. PubMed ID: 11201815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia causes ischemic bowel necrosis in rats: the role of platelet-activating factor (PAF-acether).
    Caplan MS; Sun XM; Hsueh W
    Gastroenterology; 1990 Oct; 99(4):979-86. PubMed ID: 2394352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.
    László F; Whittle BJ; Moncada S
    Br J Pharmacol; 1994 Dec; 113(4):1131-6. PubMed ID: 7889265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activating factor modulates microvascular permeability through nitric oxide synthesis.
    Ramírez MM; Quardt SM; Kim D; Oshiro H; Minnicozzi M; Durán WN
    Microvasc Res; 1995 Sep; 50(2):223-34. PubMed ID: 8538502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor: the effector of protein-rich plasma extravasation and nitric oxide synthase induction in rat immune complex peritonitis.
    Steil AA; Garcia Rodriguez MC; Alonso A; Crespo MS; Bosca L
    Br J Pharmacol; 1995 Feb; 114(4):895-901. PubMed ID: 7539698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrahydrobiopterin prevents platelet-activating factor-induced intestinal hypoperfusion and necrosis: Role of neuronal nitric oxide synthase.
    Qu XW; Thaete LG; Rozenfeld RA; Zhu Y; De Plaen IG; Caplan MS; Hsueh W
    Crit Care Med; 2005 May; 33(5):1050-6. PubMed ID: 15891335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediators of leukocyte adhesion in rat mesenteric venules elicited by inhibition of nitric oxide synthesis.
    Arndt H; Russell JB; Kurose I; Kubes P; Granger DN
    Gastroenterology; 1993 Sep; 105(3):675-80. PubMed ID: 8395443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide synthesis inhibition increases epithelial permeability via mast cells.
    Kanwar S; Wallace JL; Befus D; Kubes P
    Am J Physiol; 1994 Feb; 266(2 Pt 1):G222-9. PubMed ID: 8141295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo.
    Handa RK; Strandhoy JW; Handa SE
    Kidney Blood Press Res; 2003; 26(3):165-75. PubMed ID: 12886044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
    Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
    J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute compensation to abrupt occlusion of rat femoral artery is prevented by NO synthase inhibitors.
    Unthank JL; Nixon JC; Dalsing MC
    Am J Physiol; 1994 Dec; 267(6 Pt 2):H2523-30. PubMed ID: 7529001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-activating factor augments lipopolysaccharide-induced nitric oxide formation by rat Kupffer cells.
    Mustafa SB; Howard KM; Olson MS
    Hepatology; 1996 Jun; 23(6):1622-30. PubMed ID: 8675186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between nitric oxide and platelet-activating factor in castor-oil induced mucosal injury in the rat duodenum.
    Mascolo N; Izzo AA; Gaginella TS; Capasso F
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):680-4. PubMed ID: 8738301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide/platelet activating factor cross-talk in mesangial cells modulates the interaction with leukocytes.
    Bussolati B; Mariano F; Migliori M; Camussi G
    Kidney Int; 2002 Oct; 62(4):1322-31. PubMed ID: 12234302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed gastric emptying induced by inhibitors of nitric oxide synthase in rats.
    Plourde V; Quintero E; Suto G; Coimbra C; Taché Y
    Eur J Pharmacol; 1994 Apr; 256(2):125-9. PubMed ID: 7519557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs.
    Noguchi K; Matsuzaki T; Shiroma N; Ojiri Y; Sakanashi M
    Br J Pharmacol; 1996 Jun; 118(4):941-50. PubMed ID: 8799566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.